[ad_1] INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company with…
Tag: Radioligand
Radioligand therapy, a ‘game-changer’ for cancer treatment, forces manufacturers to race against a ticking clock
[ad_1] Novartis manufacturing associate checking punches at compressing machine. Source: Novartis In 2010, a volcano erupted in Iceland. For Dr. Oliver Sartor, a cancer research professor at the Tulane University…